Aleutian Capital Group Advises 1984 System, Inc. dba American Data in Its Sale to Valsoft Corporation
NEW YORK, April 23, 2025--(BUSINESS WIRE)--Aleutian Capital Group ("Aleutian") is pleased to announce Valsoft Corporation ("Valsoft") successful acquisition of 1984 System, Inc. dba American Data ("American Data"). Aleutian acted as the exclusive advisor to American Data throughout the entire transaction process, providing comprehensive advisory services. Terms of the deal were not disclosed.
American Data has established itself as a trusted provider of electronic health record (EHR) software for the long-term care industry, offering customizable solutions that support both clinical and administrative needs. The company serves hundreds of facilities across the United States, including skilled nursing homes and assisted living communities. With a robust, all-in-one platform and decades of industry experience, American Data is committed to delivering exceptional reliability, user support, and innovation. Its software is widely recognized for flexibility, depth of features, and seamless integration across care teams.
Aleutian's managing director, Ji Sang Lee, led the engagement with American Data, facilitating the successful transaction. "The Aleutian team was instrumental throughout our transaction process. Their strategic guidance, responsiveness, and deep understanding of the software industry gave us the confidence to navigate every step. They weren't just advisors—they were true partners who helped us secure the right outcome for our team and our future," said John Ederer, Founder and President of American Data.
About American Data
American Data is trusted by hundreds of long-term care providers across the United States for its flagship solution, ECS (Electronic Chart System)—a fully customizable electronic health record (EHR) platform tailored to the unique workflows of senior care facilities. For over 40 years, administrators, nurses, and clinical teams have relied on ECS to integrate clinical, financial, and administrative functions, enabling seamless communication, real-time decision-making, and regulatory compliance. From independent communities to large multi-site operators, American Data is known for its exceptional support, deep industry expertise, and flexible software designed to evolve with the needs of the senior care industry. Visit www.american-data.com for more information.
About Valsoft Corporation
Valsoft acquires and develops vertical market software companies that deliver mission-critical solutions. A key tenet of Valsoft's philosophy is to invest in established businesses and foster an entrepreneurial environment that shapes a company into a leader in its respective industry. Unlike private equity and VC firms, Valsoft does not have a predefined investment horizon and looks to buy, hold, and create value through long-term partnerships with existing management and customers. Visit www.valsoftcorp.com for more information.
About Aleutian Capital Group
Aleutian is a New York City based advisory group serving sellers and buyers of companies throughout North and South America, Asia, and Europe. Aleutian has expertise in technology, distribution, e-commerce, healthcare, aerospace, consumer, transportation, professional services, and industrial manufacturing industries. Our investment banking practice, through our broker-dealer Bradley Woods & Co. Ltd. (Member FINRA/SIPC), provides services relating to M&A advisory, capital raises, valuations, and recapitalizations. All securities are offered through Bradley Woods & Co. Ltd., member FINRA and SIPC. Aleutian is a division of Bradley Woods & Co. Ltd., member FINRA and SIPC. For more information, please visit www.aleutiancapital.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250423765736/en/
Contacts
Ji Sang LeeManaging DirectorAleutian Captial Groupmarketing@aleutiancapital.com
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time Business News
15 hours ago
- Time Business News
Why Medical Transcription Services Are A Must-Have
The healthcare industry has witnessed a revolutionary shift in recent years, driven largely by the widespread adoption of telemedicine. As virtual consultations become the new norm, one critical backend function has proven to be indispensable: medical transcription services. These services not only ensure that physicians and clinics maintain accurate patient records but also support efficient workflows in a digital-first environment. In 2025, the synergy between telemedicine and medical transcription is stronger than ever—and service providers like SysMD are leading the charge. In this blog, we'll explore why medical transcription services have become vital in telemedicine, how they complement medical billing services, and what to look for in a trusted partner like SysMD. Telemedicine isn't just a pandemic-era solution anymore—it's the future of healthcare delivery. As of 2025, over 70% of healthcare providers in the U.S. have incorporated virtual care into their offerings. This transition is driven by: Patient convenience and accessibility and accessibility Lower overhead costs for clinics for clinics Time-efficient consultations for physicians for physicians Technological advancements such as AI diagnostics and remote patient monitoring However, this shift has also highlighted new challenges in documentation, data accuracy, and regulatory compliance. That's where medical transcription services come in. In traditional in-person visits, physicians rely on physical notes, assistants, or EMR systems for documentation. But in telehealth settings—often involving multiple tools, video lags, or voice distortions—there's an increased chance of data misinterpretation. Here's how medical transcription services help bridge this gap: With virtual consultations, every word matters. Professional transcriptionists ensure that entire conversations—symptoms, diagnoses, treatment plans—are accurately captured and formatted. Telemedicine generates large volumes of unstructured audio or video data. Transcription converts this into clear, structured text suitable for Electronic Health Record (EHR) systems, enhancing readability and future referencing. In case of audits, lawsuits, or insurance disputes, accurate transcripts act as legally admissible documentation. HIPAA-compliant transcription partners like SysMD ensure data protection at every level. Beyond record-keeping, transcription services directly support medical billing services. Here's how they intersect: Medical coders depend on transcripts to assign correct CPT and ICD-10 codes. Misheard or mistyped terms can lead to denied claims or legal liabilities. Transcripts reduce ambiguity. With immediate and precise documentation, billing processes can begin promptly, accelerating reimbursements and improving revenue cycle management. Well-maintained transcripts create a solid audit trail, ensuring that billing aligns with clinical narratives—a requirement for Medicare, Medicaid, and private insurers. SysMD's integrated approach merges transcription and billing, streamlining the entire revenue flow for clinics and telehealth practices. When it comes to virtual care, choosing the right service provider is crucial. SysMD stands out as a trusted partner offering both medical transcription services and medical billing services under one roof. Here's what sets SysMD apart: Security is non-negotiable. SysMD adheres to stringent HIPAA regulations, using encrypted channels for data transfer, secure cloud storage, and NDA-bound transcriptionists. SysMD's real-time transcription ensures that clinicians receive structured notes within minutes after a call—ready for review, editing, or direct integration into EMR. From psychiatry and dermatology to cardiology and orthopedics, SysMD assigns domain-expert transcriptionists familiar with specialty-specific terminology. By offering both transcription and billing, SysMD removes the middle layer—reducing delays, eliminating errors, and improving payment turnaround. While human transcriptionists oversee quality control, SysMD leverages AI tools for faster voice-to-text conversions, flagging inconsistencies or missing data points for review. If you're a clinic or private practice expanding into virtual care, here are critical features to evaluate in a transcription partner: Feature Why It Matters HIPAA Compliance Ensures patient data protection and legal adherence Fast Turnaround Time Vital for urgent care or follow-up treatment Domain Expertise Medical vocabulary varies widely between specialties Integration with EHR/Billing Saves time and reduces redundancies Customization Templates, formats, and tagging should suit your workflow Support for Multilingual Patients Essential for diverse patient populations SysMD checks all these boxes, offering customizable packages for both small practices and large hospital networks. A 2024 study of 500 virtual clinics in the U.S. revealed: 37% increase in physician availability after outsourcing transcription in physician availability after outsourcing transcription 28% faster claim submissions due to aligned transcription and billing systems due to aligned transcription and billing systems 40% fewer billing rejections when accurate, timestamped transcripts were used for coding Practices using SysMD reported a 20% improvement in revenue cycle velocity and significant reductions in administrative overhead. In behavioral health, every spoken word is critical. A therapist working with a virtual clinic uses SysMD's transcription to document patient narratives, treatment plans, and medication updates—ensuring continuity of care and defensible notes for insurance claims. A dermatology clinic records voice memos after tele-consults. SysMD transcribes these memos, tags them with relevant ICD codes, and sends them directly to the billing team—compressing the entire process into hours, not days. A multi-physician telehealth group relies on SysMD's real-time transcription and EMR integration. This allows physicians to focus on patient interaction while the backend handles records and claims prep. As telehealth platforms continue to evolve with AI triage tools, wearable integrations, and asynchronous care models, transcription services must also advance. In 2025 and beyond, expect: Voice Command Documentation: Doctors dictating in real time to smart systems Doctors dictating in real time to smart systems Multimodal Transcription: Audio, video, and chat-based note conversion Audio, video, and chat-based note conversion Predictive Documentation: AI suggesting notes based on past consults AI suggesting notes based on past consults Multilingual Transcription at Scale: Catering to increasingly diverse patient populations SysMD is already developing tools in these areas, ensuring that their clients stay ahead of the digital health curve. In the era of telemedicine, medical transcription services are more than a luxury—they are a necessity. From capturing clinical insights accurately to supporting revenue generation through medical billing services, transcription is a foundational pillar of virtual healthcare success. With providers like SysMD offering integrated, compliant, and tech-enabled solutions, medical practices can embrace telehealth confidently—knowing that their documentation, billing, and compliance needs are in expert hands. TIME BUSINESS NEWS
Associated Press
a day ago
- Associated Press
Valsoft Corporation Acquires collectionHQ, Global Leader in Library Collection Performance Solutions
MONTRÉAL, QC / ACCESS Newswire / June 27, 2025 / Valsoft Corporation Inc. ('Valsoft'), a Montreal-based company specializing in the acquisition and development of vertical market software businesses, is pleased to announce the acquisition of collectionHQ, the world's leading provider of data-driven collection performance improvement solutions for libraries. Founded in Glasgow, United Kingdom, collectionHQ was introduced to the public library market in 2008 as a solution to help librarians integrate the Evidence Based Stock Management (EBSM®) methodology into their workflows. As the only tool on the market delivering actionable, data-driven insights, collectionHQ quickly gained traction across the UK, United States, Canada, Australia, and New Zealand, becoming one of the most talked-about innovations in the public library sector. Most recently, collectionHQ has extended its proven technology to academic institutions with the launch of cHQacademic, a new solution designed to help academic libraries make informed, efficient decisions that enhance the student experience. 'collectionHQ is a strong fit with Valsoft's mission of acquiring and growing market-leading vertical software companies,' said Peter Blanchard, Portfolio Vice President, Valsoft. 'Their track record of innovation and dedication to serving the evolving needs of libraries worldwide aligns perfectly with our long-term vision. We're proud to welcome them to the Valsoft family.' 'We are excited to enter this new chapter with Valsoft,' said Amandeep Kochar, CEO of Baker & Taylor. 'Their experience scaling software companies globally makes them an ideal partner as we continue to evolve our solutions and serve the needs of public and academic libraries around the world.' collectionHQ will continue to operate under its existing brand and leadership, with a focus on expanding into new markets, strengthening customer relationships, and driving product innovation. Valsoft was represented internally by David Felicissimo (General Counsel), Oliver Gray (Senior Legal Counsel) and Elisa Marcon (Corporate Paralegal). Bridgeall Libraries Limited (the seller of the collectionHQ business) was represented by Ryan Alexander of Offit Kurman and Katy Poole of Buckles Law. About collectionHQ collectionHQ is the world's leading provider of collection performance improvement solutions for libraries. Based on the proven Evidence Based Stock Management (EBSM®) methodology that has been used in libraries for almost thirty years, collectionHQ's products harness cutting-edge technology to analyze data about the library's collection and how it has been used over time to deliver easy-to-use action plans that support continuous improvements. With flexible solutions to accommodate public and academic libraries of all sizes, collectionHQ's team of librarians and data experts provide ongoing support to help optimize workflows, save time and money, improve turnover, and align collections with user demand. About Valsoft Corporation Valsoft Corporation acquires and develops vertical market software companies with the goal of driving long-term growth and value creation. Valsoft partners with companies to provide operational support, capital, and strategic expertise while allowing them to retain their entrepreneurial spirit. Headquartered in Montreal, Valsoft has a presence in over 20 countries and operates in more than 30 vertical markets. Media contact information Thierry Tardif Communications and Public Relations Valsoft Corporation +1 514-799-6679 [email protected] SOURCE: Valsoft Corp press release
Medscape
2 days ago
- Medscape
Diabetes Drug Tied to Decreased Dementia Risk in T2D
TOPLINE: Semaglutide was associated with a 20%-46% reduced risk for Alzheimer's disease (AD)-related dementia in patients with type 2 diabetes (T2D) compared with other antidiabetic medications, with a particularly strong protective effect against vascular dementia, new research showed. METHODOLOGY: Researchers examined electronic health records (EHRs) of more than 1.7 million US adults with T2D with or without obesity and with no prior diagnosis of AD or AD-related dementia. They compared semaglutide (n = 64,267 users) to seven other antidiabetic medications (n = 1,646,728 users) on the first-time diagnosis of AD-related dementia, as well as the subtypes of vascular dementia, frontotemporal dementia (FTD), and Lewy body dementia, during a 3-year follow-up. The other antidiabetic medications included insulin, metformin, DPP-4 inhibitors, SGLT2 inhibitors, sulfonylurea, thiazolidinedione, and first-generation GLP-1 receptor agonists (albiglutide, dulaglutide, exenatide, liraglutide, and lixisenatide). Secondary outcomes included prescriptions of dementia-related medications. TAKEAWAY: Semaglutide was associated with a significantly reduced risk for AD-related dementia compared to insulin (hazard ratio [HR], 0.54), metformin (HR, 0.67), and older GLP-1 receptor agonists (HR, 0.80). Protection against vascular dementia was also greater for semaglutide compared to insulin (HR, 0.48), metformin (HR, 0.55), and GLP-1 receptor agonists (HR, 0.67). No significant associations were found between the use of semaglutide and the risk for FTD or Lewy body dementia. The link between semaglutide and reduced AD-related dementia risk vs insulin, metformin, and GLP-1 receptor agonists was stronger in younger adults (mean age, 51.7 years) compared to older adults (mean age, 70.9 years), with risk reductions ranging from 32% to 56% vs 20% to 39%. The use of semaglutide vs other antidiabetic medications was associated with significantly fewer prescriptions of dementia-related medications. IN PRACTICE: 'There is no cure or effective treatment for dementia, so this new study provides real-world evidence for its potential impact on preventing or slowing dementia development among at high-risk population,' Rong Xu, Case Western Reserve University School of Medicine, Cleveland, said in a press release. 'Future works are needed to establish causal relationships through randomized clinical trials and to characterize the underlying mechanisms,' the investigators wrote. SOURCE: This study was led by William Wang, Case Western Reserve University School of Medicine, Cleveland. It was published online on June 24 in the Journal of Alzheimer's Disease. LIMITATIONS: This retrospective, observational, EHR-based study was limited by potential over-, under-, or misdiagnosis; unmeasured confounders; and a short 3-year follow-up period. Diagnosis of AD-related dementia relied on International Classification of Diseases, 10th Revision codes and prescription data, which may have lacked precision. This study also lacked data on medication adherence, cognitive function tracking, and genetic profiles, and could not fully adjust for variation of healthcare use. DISCLOSURES: This study was funded by grants from the National Institute on Aging and the National Center for Advancing Translational Sciences. One investigator reported being the editor in chief of the publishing journal but was not involved in the peer-review process. The other investigators reported having no relevant financial conflicts. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
